@article{0d42f3a186374bd6a585ef11f86ca464,
title = "Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials",
author = "Garmendia, \{Craig A.\} and \{Nassar Gorra\}, Liliana and Rodriguez, \{Ana Lucia\} and Trepka, \{Mary Jo\} and Emir Veledar and Purnima Madhivanan",
note = "Funding Information: Dr Garmendia received funding through the Federal Employee Education and Assistance Fund/National Treasury Employee Union. Ms Rodriguez was funded by The Global Health Equity Scholars Program, National Institutes of Health (NIH) (FIC D43TW010540). Funding Information: Conflict of Interest Disclosures: Dr Garmendia reported grants from Federal Employee Education and Assistance Fund/National Treasury Employee Union during the conduct of the study. Ms Rodriguez reported funding from a predoctoral training program by The Fogarty Institute (Global Health Equity Scholars Program) National Institutes of Health (NIH) FIC D43TW010540. No other disclosures were reported. Funding/Support: Dr Garmendia received funding through the Federal Employee Education and Assistance Fund/National Treasury Employee Union. Ms Rodriguez was funded by The Global Health Equity Scholars Program, National Institutes of Health (NIH) (FIC D43TW010540). Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.",
year = "2019",
month = apr,
doi = "10.1001/jamainternmed.2018.7661",
language = "English (US)",
volume = "179",
pages = "582--584",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "4",
}